fbpx
Wikipedia

Dechra Pharmaceuticals

Dechra Pharmaceuticals plc is a business involved in the development and marketing of veterinary products based in Northwich, England. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Dechra Pharmaceuticals plc
TypePublic
LSE: DPH
FTSE 250 component
IndustryPharmaceuticals
Founded1997
HeadquartersNorthwich, England, UK
Key people
Tony Rice, (Chairman)
Ian Page, (CEO)
Revenue £608.0 million (2021)[1]
£162.2 million (2021)[1]
£55.5 million (2021)[1]
Number of employees
1,700 (2022)[2]
Websitewww.dechra.com

History

The Company was founded in 1997 by way of a management buy-out from Lloyds Chemists.[3] It was first listed on the London Stock Exchange in 2000.[3] In 2007 it bought VetXX, a Danish veterinary products business, for £62 million.[4] In 2010 it purchased Florida-based DermaPet for US$64 million[5] and Sussex-based Genitrix for £5 million.[6]

It sold its veterinary services business to US-firm, Patterson Companies, for £87.5m in July 2013 in order to focus on its higher margin manufacturing business.[7]

Operations

The Company sells pharmaceuticals - mainly for dogs, cats, equine and food producing animals; products include Vetoryl for Cushing's disease in dogs and Felimazole for hyperthyroidism in cats. It is organised into two divisions: European Pharmaceuticals and US Pharmaceuticals.[8]

See also

References

  1. ^ a b c "Annual Report 2021" (PDF). Dechra Pharmaceuticals. Retrieved 14 February 2022.
  2. ^ "Dechra Pharmaceuticals". Craft. Retrieved 14 July 2022.
  3. ^ a b "Montague Private Equity announces sale of VetXX".
  4. ^ "Dechra Pharma to buy VetXX for 61.7 mln stg". Reuters. 12 December 2007. Retrieved 28 March 2015.
  5. ^ "Dechra Pharma buys DermaPet for US$64 mln". Proactive Investors. 22 October 2010. Retrieved 1 March 2020.
  6. ^ "Dechra acquires Sussex-based Genitrix in a £5.4m deal". Business Live. 1 December 2010. Retrieved 1 March 2020.
  7. ^ "Dechra sells up". Investors Chronicle. 11 July 2013. Retrieved 16 March 2014.
  8. ^ "Dechra Pharmaceuticals PLC". dechraplc.com. Retrieved 28 March 2015.

dechra, pharmaceuticals, business, involved, development, marketing, veterinary, products, based, northwich, england, listed, london, stock, exchange, constituent, ftse, index, plctypepublictraded, aslse, dphftse, componentindustrypharmaceuticalsfounded1997hea. Dechra Pharmaceuticals plc is a business involved in the development and marketing of veterinary products based in Northwich England It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index Dechra Pharmaceuticals plcTypePublicTraded asLSE DPHFTSE 250 componentIndustryPharmaceuticalsFounded1997HeadquartersNorthwich England UKKey peopleTony Rice Chairman Ian Page CEO Revenue 608 0 million 2021 1 Operating income 162 2 million 2021 1 Net income 55 5 million 2021 1 Number of employees1 700 2022 2 Websitewww wbr dechra wbr com Contents 1 History 2 Operations 3 See also 4 ReferencesHistory EditThe Company was founded in 1997 by way of a management buy out from Lloyds Chemists 3 It was first listed on the London Stock Exchange in 2000 3 In 2007 it bought VetXX a Danish veterinary products business for 62 million 4 In 2010 it purchased Florida based DermaPet for US 64 million 5 and Sussex based Genitrix for 5 million 6 It sold its veterinary services business to US firm Patterson Companies for 87 5m in July 2013 in order to focus on its higher margin manufacturing business 7 Operations EditThe Company sells pharmaceuticals mainly for dogs cats equine and food producing animals products include Vetoryl for Cushing s disease in dogs and Felimazole for hyperthyroidism in cats It is organised into two divisions European Pharmaceuticals and US Pharmaceuticals 8 See also EditPharmaceutical industry in the United KingdomReferences Edit a b c Annual Report 2021 PDF Dechra Pharmaceuticals Retrieved 14 February 2022 Dechra Pharmaceuticals Craft Retrieved 14 July 2022 a b Montague Private Equity announces sale of VetXX Dechra Pharma to buy VetXX for 61 7 mln stg Reuters 12 December 2007 Retrieved 28 March 2015 Dechra Pharma buys DermaPet for US 64 mln Proactive Investors 22 October 2010 Retrieved 1 March 2020 Dechra acquires Sussex based Genitrix in a 5 4m deal Business Live 1 December 2010 Retrieved 1 March 2020 Dechra sells up Investors Chronicle 11 July 2013 Retrieved 16 March 2014 Dechra Pharmaceuticals PLC dechraplc com Retrieved 28 March 2015 Retrieved from https en wikipedia org w index php title Dechra Pharmaceuticals amp oldid 1127923144, wikipedia, wiki, book, books, library,

article

, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games.